Evidence map›Paper›PMID 37799946›Full record

ArticleEcancermedicalscience2023

Assessment of barriers to optimal cancer control in adult cancer treatment centres in Cameroon.

Berthe Sabine Esson Mapoko, Andreas Frambo, Yauba Saidu, Esther Dina Bell Mbassi, Etienne Atenguena, Kareen Azemafac, Emily Kobayashi, Lionel Tabola, Glenda Nkeng, Anne Sango and 13 more

Open access · goldAbstract read
In one paragraph

Article in Ecancermedicalscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 3 countries.

Berthe Sabine Esson MapokoFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Andreas FramboClinton Health Access Initiative, Yaoundé 99322, Cameroon.
Yauba SaiduClinton Health Access Initiative, Yaoundé 99322, Cameroon.
Esther Dina Bell MbassiFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala 99322, Cameroon.
Etienne AtenguenaFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Kareen AzemafacFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Emily KobayashiClinton Health Access Initiative, Yaoundé 99322, Cameroon.
Lionel TabolaFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Glenda NkengFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Anne SangoFaculty of Health Sciences, University of Buea, Buea 99322, Cameroon.
Anne Marthe MaisonFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala 99322, Cameroon.
Sidonie Ananga NoaFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala 99322, Cameroon.
Ambroise NtamaFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala 99322, Cameroon.
Ruth Rosine Meka'h MapenyaFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Rachel TayouFaculty of Health Sciences, University of Dschang, Dschang 99322, Cameroon.
Francine KouyaMbingo Baptist Hospital, Bamenda 99322, Cameroon.
Glenn MbahMbingo Baptist Hospital, Bamenda 99322, Cameroon.
Pelagie DouanlaFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Celestin FonkwaLaquintinie Hospital oF Douala, Douala 99322, Cameroon.
Martin Essomba BiwoleFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala 99322, Cameroon.
Zacharie SandoFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Albert Mouelle SoneFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala 99322, Cameroon.
Paul NdomFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé 99322, Cameroon.
Université de Yaoundé I · CMUniversity of Douala · CMClinton Health Access Initiative · USCameroon Baptist Convention Health Services · CMUniversité de Dschang · CMUniversity of Bamenda · CMUniversity of Buea · CMUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 20,745 new cases of cancer were registered annually with 13,199 (64%) deaths in 2020 in Cameroon. Despite the increasing cancer burden, there is a paucity of reliable data that can enhance decision-making for cancer control in Cameroon. This assessment was, therefore, designed to generate data that may enable stakeholders, policymakers and funders to make data-driven decisions on cancer control. We conducted a cross-sectional survey in July 2020, which enabled us to collect data on key cancer variables from six adult cancer treatment centres in Cameroon. The key components of the assessment included case detection, service availability, human resource capacity, cost of chemotherapy and radiotherapy, the safety of chemotherapy sessions, data systems, patient education, palliative care, funding for chemotherapy and chemotherapy stock. Data were compiled and analysed using Microsoft Excel 2016. Data from four of the 6 sites show that 1,636 new cases were recorded representing an annual case detection rate of 11.8%. All the six assessed facilities offered chemotherapy services, 5/6 (83.3%) offered surgery for cancers, while just 1 (16.7%) offered radiotherapy services. In addition, none offered nuclear medicine services for cancer care and treatment. Similarly, none of the facilities had the WHO-recommended number of human resources for optimal cancer care. Overall, there were only 6 medical oncologists, 2 surgical oncologists, 3 radiation oncologists and 14 oncology nurses providing services across the 6 cancer treatment centres. Treatment services are expensive for an average national, with a complete course of chemotherapy followed by radiotherapy costing ~XAF 1,240,000 (~$2,480). None of the survey facilities had a recommended safe biosafety cabinet and clean room for the preparation of chemotherapies, rendering the preparation of chemotherapies suboptimal and hazardous. Data collection tools were manual, relatively available and very different across all the surveyed sites and the interval for data collection and transmission was collectively undefined. Optimal cancer care in adult cancer treatment centres is limited by several health systems and socio-economic factors. The identification of these barriers has enabled the formulation of action-oriented interventions, leveraging on the recently adopted national strategy for the prevention and control of cancers in the country.

Indexed as

assessmentbarriersCamerooncancer control

Identifiers

PMID37799946
PMCPMC10550327
OpenAlexW4386935176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.